Sunwoda Electronic Co.,Ltd (SHE:300207)
China · Delayed Price · Currency is CNY 21.35
-0.23 (-1.07%)
Aug 1, 2025, 3:04 PM CST
Akoya Biosciences Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 57,103 | 55,790 | 47,464 | 51,639 | 37,095 | 29,485 | Upgrade |
Other Revenue | 231.1 | 231.1 | 398.69 | 522.84 | 263.82 | 207.06 | Upgrade |
| 57,334 | 56,021 | 47,862 | 52,162 | 37,359 | 29,692 | Upgrade | |
Revenue Growth (YoY) | 18.56% | 17.05% | -8.24% | 39.63% | 25.82% | 17.64% | Upgrade |
Cost of Revenue | 48,809 | 47,819 | 41,744 | 45,565 | 32,036 | 25,562 | Upgrade |
Gross Profit | 8,525 | 8,202 | 6,118 | 6,597 | 5,322 | 4,130 | Upgrade |
Selling, General & Admin | 3,807 | 3,654 | 3,129 | 2,747 | 1,774 | 1,313 | Upgrade |
Research & Development | 3,552 | 3,330 | 2,711 | 2,742 | 2,327 | 1,794 | Upgrade |
Other Operating Expenses | -6.43 | -76.26 | -113.1 | 133.83 | 96.35 | 104.11 | Upgrade |
Operating Expenses | 7,432 | 6,987 | 5,730 | 5,681 | 4,203 | 3,253 | Upgrade |
Operating Income | 1,094 | 1,215 | 388.13 | 915.86 | 1,119 | 876.69 | Upgrade |
Interest Expense | -709.15 | -680.71 | -732.88 | -664.56 | -531.49 | -420.99 | Upgrade |
Interest & Investment Income | 597.81 | 532.28 | 422.05 | 238.9 | 129.3 | 140.06 | Upgrade |
Currency Exchange Gain (Loss) | 10.99 | 10.99 | 74.82 | -156.27 | -25.86 | -119.28 | Upgrade |
Other Non Operating Income (Expenses) | 2.24 | -38.56 | -8.36 | -152.18 | -27.12 | -49.98 | Upgrade |
EBT Excluding Unusual Items | 995.5 | 1,039 | 143.77 | 181.76 | 663.87 | 426.5 | Upgrade |
Gain (Loss) on Sale of Investments | -261.68 | -326.3 | -63.43 | -45.48 | -23.68 | 418.04 | Upgrade |
Gain (Loss) on Sale of Assets | -156.95 | -154.06 | -60.24 | -21.37 | 158.89 | -11.7 | Upgrade |
Asset Writedown | -49.24 | -57.12 | -18.82 | -11.36 | -9.05 | -36.7 | Upgrade |
Other Unusual Items | 308.34 | 273.45 | 167 | 335.97 | 228.05 | 171.12 | Upgrade |
Pretax Income | 835.98 | 774.66 | 168.27 | 439.51 | 1,018 | 967.26 | Upgrade |
Income Tax Expense | 308.56 | 254.46 | -162.48 | -323.85 | 163.09 | 166.99 | Upgrade |
Earnings From Continuing Operations | 527.42 | 520.2 | 330.75 | 763.36 | 854.99 | 800.26 | Upgrade |
Minority Interest in Earnings | 1,008 | 948.04 | 745.45 | 304.65 | 60.66 | 1.69 | Upgrade |
Net Income | 1,536 | 1,468 | 1,076 | 1,068 | 915.65 | 801.96 | Upgrade |
Net Income to Common | 1,536 | 1,468 | 1,076 | 1,068 | 915.65 | 801.96 | Upgrade |
Net Income Growth | -1.52% | 36.43% | 0.77% | 16.64% | 14.18% | 6.79% | Upgrade |
Shares Outstanding (Basic) | 1,850 | 1,859 | 1,856 | 1,723 | 1,579 | 1,542 | Upgrade |
Shares Outstanding (Diluted) | 1,850 | 1,859 | 1,856 | 1,723 | 1,606 | 1,542 | Upgrade |
Shares Change (YoY) | -0.90% | 0.16% | 7.72% | 7.23% | 4.16% | -0.31% | Upgrade |
EPS (Basic) | 0.83 | 0.79 | 0.58 | 0.62 | 0.58 | 0.52 | Upgrade |
EPS (Diluted) | 0.83 | 0.79 | 0.58 | 0.62 | 0.57 | 0.52 | Upgrade |
EPS Growth | -0.63% | 36.21% | -6.45% | 8.77% | 9.62% | 7.12% | Upgrade |
Free Cash Flow | -2,076 | -2,903 | -2,278 | -8,535 | -2,226 | -3,116 | Upgrade |
Free Cash Flow Per Share | -1.12 | -1.56 | -1.23 | -4.96 | -1.39 | -2.02 | Upgrade |
Dividend Per Share | 0.150 | 0.150 | 0.120 | 0.080 | 0.070 | 0.070 | Upgrade |
Dividend Growth | 25.00% | 25.00% | 49.99% | 14.27% | 0.02% | - | Upgrade |
Gross Margin | 14.87% | 14.64% | 12.78% | 12.65% | 14.25% | 13.91% | Upgrade |
Operating Margin | 1.91% | 2.17% | 0.81% | 1.76% | 3.00% | 2.95% | Upgrade |
Profit Margin | 2.68% | 2.62% | 2.25% | 2.05% | 2.45% | 2.70% | Upgrade |
Free Cash Flow Margin | -3.62% | -5.18% | -4.76% | -16.36% | -5.96% | -10.49% | Upgrade |
EBITDA | 2,880 | 2,957 | 1,955 | 2,129 | 1,926 | 1,388 | Upgrade |
EBITDA Margin | 5.02% | 5.28% | 4.08% | 4.08% | 5.16% | 4.67% | Upgrade |
D&A For EBITDA | 1,786 | 1,742 | 1,567 | 1,214 | 806.88 | 511.47 | Upgrade |
EBIT | 1,094 | 1,215 | 388.13 | 915.86 | 1,119 | 876.69 | Upgrade |
EBIT Margin | 1.91% | 2.17% | 0.81% | 1.76% | 3.00% | 2.95% | Upgrade |
Effective Tax Rate | 36.91% | 32.85% | - | - | 16.02% | 17.27% | Upgrade |
Revenue as Reported | 57,334 | 56,021 | 47,862 | 52,162 | 37,359 | 29,692 | Upgrade |
Advertising Expenses | - | 36 | 20.81 | 3.89 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.